Evidence map›Paper›PMID 30498855›Full record

ArticleSurgical endoscopy2019

Laparoscopic versus open mesohepatectomy for patients with centrally located hepatocellular carcinoma: a propensity score matched analysis.

Wei Li, Jun Han, Guowei Xie, Yang Xiao, Ke Sun, Kefei Yuan, Hong Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Minimally Invasive vs Open Major Hepatectomies for Liver Malignancies: a Propensity Score-Matched Analysis.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2022
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Wei LiDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Jun HanDepartment of Critical Care Medicine, Sichuan Provincial Hospital for Women and Children, Chengdu, 610045, Sichuan, China.
Guowei XieDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Yang XiaoDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Ke SunDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.
Kefei YuanDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. ykf13@163.com.
Hong WuDepartment of Liver Surgery and Liver Transplantation Centre, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China. wuhong7801@163.com.
Sichuan University · CNChengdu Women's and Children's Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough laparoscopic mesohepatectomy (LM) has been performed for patients with centrally located hepatocellular carcinoma (CL-HCC), its short- and long-term benefits compared with traditional open surgery remain unclear. The aim of the present study was to explore the independent role of LM in the prognosis of patients with CL-HCC.

methodsA retrospective analysis was undertaken of 348 patients who underwent mesohepatectomy for CL-HCC between January 2012 and October 2017 in our hospital. The impact of the surgical methods on long-term prognosis was evaluated by multivariable regression analysis. In addition, patients in the LM group were matched in a 1:3 ratio with open mesohepatectomy (OM) group.

resultsSome 307 patients underwent OM and 41 had LM. In both adjusted and non-adjusted models, patients in LM group had similar overall survival (OS, both P > 0.05) and disease-free survival (DFS, both P > 0.05) compared to OM patients. The mean (s.d.) OS in LM and OM groups was 41.6 (7.2) and 46.4 (1.4) months, respectively. The mean (s.d.) DFS in LM and OM groups was 37.7 (5.9) and 33.4 (1.5) months, respectively. After propensity score-matched (PSM) analysis, 96 patients remained in OM group and 32 patients in LM group. In the PSM subset, patients in LM group still had comparable OS (P = 0.120) and DFS (P = 0.757) compared to patients in the OM group. After PSM, patients receiving LM had longer vascular exclusion time (P = 0.006) and shorter hospital stay (P = 0.004). In addition, LM was associated with reduced postoperative morbidity after PSM adjustment (P = 0.026).

conclusionsLM is associated with fewer complications and does not compromise survival compared with OM. LM can be recommended as a safe and reasonable surgical option in selected patients with CL-HCC.

Indexed as

Propensity ScoreCarcinoma, HepatocellularDisease-Free SurvivalFemaleHepatectomyHumansLaparoscopyLiverLiver NeoplasmsMaleMiddle AgedNeoplasm StagingPrognosisRetrospective StudiesTomography, X-Ray ComputedTreatment OutcomeHepatocellular carcinomaLaparoscopyMesohepatectomyPrognosis

Identifiers

PMID30498855
OpenAlexW2902831773

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.